Illumina (ILMN) vs Molina Healthcare (MOH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Illumina (ILMN) has outperformed Molina Healthcare (MOH) over the past year, gaining 177.0% versus a loss of 4.2%. Over five years, MOH leads with a -30.4% price change compared with -32.9% for ILMN. Illumina is the larger company by market cap ($39.04 billion vs $10.21 billion), about 3.8 times the size, while Molina Healthcare is growing revenue faster (+11.7% vs -0.7%).
On valuation, Molina Healthcare trades at a lower forward P/E (20.1x vs 42.3x for Illumina). Illumina converts more of its revenue into profit, with a net margin of 19.6% versus 1.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ILMN | MOH |
|---|---|---|
| Share price | $258.56 | $195.69 |
| Market cap | $39.04B | $10.21B |
| 1-day change | -3.44% | +0.44% |
| YTD return | +104.15% | +12.26% |
| 1-year return | +176.95% | -4.15% |
| 5-year return | -32.85% | -30.44% |
| P/E ratio (TTM) | 48.24 | — |
| Forward P/E | 42.26 | 20.08 |
| EPS (TTM) | $5.36 | $0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.34B | $45.43B |
| Revenue growth (YoY) | -0.66% | +11.75% |
| Net income (latest FY) | $850.00M | $472.00M |
| Gross margin | 66.08% | 13.07% |
| Operating margin | 18.58% | 1.72% |
| Net margin | 19.57% | 1.04% |
| 52-week high | $309.35 | $244.89 |
| 52-week low | $88.00 | $121.06 |
| Distance from 52-week high | -16.42% | -20.09% |
| Analyst consensus | buy | hold |
| Avg. price target upside | -13.42% | +6.87% |
| Average volume | 2.66M | 912.95K |
| Shares outstanding | 151.00M | 52.20M |
| Employees | 8,600 | 19,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Illumina is about 3.8 times larger than Molina Healthcare by market value ($39.04B vs $10.21B).
- ILMN has outperformed MOH by 181.1 percentage points over the past year.
- Illumina is more profitable, keeping 19.6 cents of every revenue dollar as net income versus 1.0 cents for Molina Healthcare.
- Molina Healthcare grew revenue faster in its latest fiscal year (+11.75% vs -0.66%).
About Illumina
ILMN stock →Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Health Care · Medical Specialities · 8,600 employees
About Molina Healthcare
MOH stock →Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.
Health Care · Medical Specialities · 19,000 employees
ILMN vs MOH FAQ
Which is bigger, Illumina or Molina Healthcare?
Illumina (ILMN) is larger, with a market capitalization of $39.04B compared with $10.21B for Molina Healthcare (MOH).
Which stock has performed better over the past year, ILMN or MOH?
ILMN returned +176.95% over the past 12 months, compared with -4.15% for MOH (price return, excluding dividends). Past performance does not predict future results.
Are Illumina and Molina Healthcare in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.